據報匯控(00005.HK)促恆生(00011.HK)出售香港地產不良貸款組合
據《彭博》引述知情人士報道,匯控(00005.HK)近期罕有地直接介入旗下恆生銀行(00011.HK)的壞賬處理,過去兩個月從倫敦總部派出球首席企業信貸官及特別信貸部門主管,督促恆生啓動出售香港房地產不良貸款組合的程序,預料涉及超過30億美元。
報道指,截至今年6月底,恆生銀行的香港商業房地產不良貸款額達約250億港元,較去年同期大幅增加85%。惠譽評級基於金管局數據估算,香港銀行業整體不良貸款總額達到約250億美元。匯豐發言人就表示對市場傳聞不予置評,又指所有銀行都會持續不斷地優化其信貸組合及管理風險。恆生對報道不予置評,並補充指是按國際法規及會計準則管理信貸風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.